News Release - February 16, 2007

Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union

Source: Tibotec Pharmaceuticals

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.